Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics and tolerability of Delafloxacin in subjects with varying degrees of renal function

Next Previous
Trial Profile

Pharmacokinetics and tolerability of Delafloxacin in subjects with varying degrees of renal function

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 02 Apr 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Delafloxacin (Primary) ; Delafloxacin (Primary)
  • Indications Community-acquired pneumonia; Skin and soft tissue infections; Urinary tract infections
  • Focus Adverse reactions; Pharmacokinetics

Most Recent Events

  • 26 Mar 2018 Results (n=44) assessing pharmacokinetics and tolerability of Delafloxacin in subjects with varying degrees of renal function, were published in the Journal of Clinical Pharmacology.
  • 14 Mar 2018 Results assessing pharmacokinetics between healthy subjects and subjects with end-stage renal disease (n=19) published in the Journal of Clinical Pharmacology
  • 02 Jan 2018 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top